The most serious adverse reactions were those of skin infections, predominantly cellulitis, reported more commonly in the Prolia group compared with placebo (0.4 percent vs. 0.1 percent) in ...

In addition, adverse event reports submitted to the FDA suggested in a separate, internal study that patients on dialysis treated with Prolia are at "substantial risk for severe and symptomatic ...

Within 12 months, BMD will return to pretreatment levels. Talk with your health care provider if you plan on stopping Prolia. How Can I Prevent and Manage Side Effects?

Adverse effects (AEs) commonly reported in patients administered Prolia include back pain, muscle pain, and pain in the arms or legs. Other serious AEs associated with Prolia include confusion, ...

Adults who continued using denosumab had a lower risk for developing incident diabetes than adults who discontinued denosumab after the first dose (HR = 0.84; 95% CI, 0.78-0.9).

THOUSAND OAKS, Calif., Nov. 5, 2010 /PRNewswire/ -- Amgen (Nasdaq: AMGN) is pleased to announce that it has won the Best New Drug award for Prolia™ (denosumab), a novel treatment approved in the ...

Doctors acknowledge Prolia can have serious side effects, but they're rare and the risk of a life-changing injury or death from osteoporosis is far greater.

I am not really interested in taking an oral prescription such as Fosamax, because of the many negative side effects. I would like to find out more about the injection, Prolia.

The retrospective, observational study assessed U.S. Medicare beneficiary data on 478,651 postmenopausal women aged 66 or older with no history of prior osteoporosis treatment who initiated Prolia ...

Prolia, a new injectable drug to treat osteoporosis in postmenopausal women at high risk of fractures has been approved by the US Food and Drug Administration (FDA).